血清胃蛋白酶原I与体重指数的性别特异性差异
该横断面研究纳入中国福建地区2263名完成血清胃蛋白酶原(PG)和幽门螺杆菌(HP)IgG抗体检测的表观健康参与者,采用ELISA法测PG、胶体金免疫法测HP抗体。结果发现男性低PG I(<70 μg/L)者BMI和血清尿酸升高,超重是男性低PG I的独立危险因素(OR 1.519;p=0.017),女性无此关联。提示临床应用血清PG I时应考虑性别二态性。
要点
- 男性低PG I(<70 μg/L)与超重独立相关(OR 1.519;p=0.017)。
- 女性中未发现低PG I与超重的关联。
- 临床应用血清PG I筛查胃癌时应考虑性别差异。
核心结论
- 在中国东南沿海地区观察到血清低PG I与超重的关联存在性别特异性,男性超重是低PG I的独立危险因素,女性无此关联。
- 临床利用血清PG I时不应忽视性别二态性的影响。
研究设计与样本
- 横断面研究,在福建省招募4299名表观健康参与者,最终纳入2263名完成血清PG和抗HP IgG抗体检测者。
- 血清PG用ELISA法自动检测,血清HP-IgG抗体用胶体金免疫分析法检测,临床特征通过问卷获取。
主要发现
- 男性低PG I值(<70 μg/L)者观察到BMI和血清尿酸升高。
- 多因素logistic回归显示超重是男性低PG I的独立危险因素(OR 1.519;p=0.017)。
- 女性中未发现超重与低PG I的关联。
关键数值与推荐
- 低PG I定义为<70 μg/L。
- 男性超重与低PG I关联的OR为1.519(p=0.017)。
临床怎么用
- 解读男性血清PG I结果时需结合BMI评估,超重男性低PG I可能受体重影响而非仅胃黏膜状态。
- 女性PG I解读无需按BMI分层,但仍需结合HP感染等临床信息综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The clinical significance of serum pepsinogen (PG) for screening gastric cancer has been a controversial topic. Serum PG I levels have been demonstrated to be correlated with age, sex, and the Helicobacter pylori (HP) infection. However, the underlying factors that influence serum PG I variations remain to be fully elucidated. We aimed to evaluate the impacts of sex and body mass index (BMI) on PG I in Chinese population. METHODS: The cross-sectional study recruited 4,299 apparently healthy participants in Fujian Province. Serum PG levels were automatically measured using ELISA method. Serum H. pylori-IgG antibody was detected by the colloidal gold immunoassay. Clinical characteristics were obtained by questionnaire. RESULTS: Totally, 2,263 participants who had tests of serum PG and anti-HP IgG antibody were enrolled. Increased BMI and serum uric acid were observed in males with low PG I value (<70 μg/L). Multiple logistic regression showed the presence of overweight was the independent risk factor for male participants with low PG I level (odds ratio [OR] 1.519; p=0.017). However, the association was not found in females. CONCLUSIONS: Sex-specific association of serum low PG I with overweight was observed in the southeast coastal areas of China. Thus, effects of sexual dimorphism should not be ignored during the clinical utilization of serum PG I.
引用
- Xu W, Yang B, Lin S, et al. Sex-specific disparities of serum pepsinogen I in relation to body mass index. Clin Chem Lab Med. 2023. PMID: 37171227. doi:10.1515/cclm-2023-0236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。